These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25555778)

  • 1. Multipurpose prevention technologies for reproductive and sexual health.
    Stone A
    Reprod Health Matters; 2014 Nov; 22(44):213-7. PubMed ID: 25555778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond HIV microbicides: multipurpose prevention technology products.
    Malcolm RK; Boyd P; McCoy CF; Murphy DJ
    BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women.
    Hynes JS; Sheth AN; Lathrop E; Sales JM; Haddad LB
    J Womens Health (Larchmt); 2019 May; 28(5):665-672. PubMed ID: 30615569
    [No Abstract]   [Full Text] [Related]  

  • 4. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
    Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
    Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products.
    Schelar E; Polis CB; Essam T; Looker KJ; Bruni L; Chrisman CJ; Manning J
    Contraception; 2016 Jan; 93(1):32-43. PubMed ID: 26385588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritizing multipurpose prevention technology development and investments using a target product profile.
    Romano J; Manning J; Hemmerling A; McGrory E; Holt BY
    Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
    Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.
    Boonstra H; Barot S; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():23-6. PubMed ID: 25335837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipurpose Prevention Technologies: A Global Sexual and Reproductive Health Priority.
    Guilamo-Ramos V; Reading M; Bowman AS; Perlman DC; Barrett S
    J Assoc Nurses AIDS Care; 2018; 29(1):6-9. PubMed ID: 28760598
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging Technologies to Prevent Pregnancy and Sexually Transmitted Infections in Women.
    Seidman D; Hemmerling A; Smith-McCune K
    Semin Reprod Med; 2016 May; 34(3):159-67. PubMed ID: 26956691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
    Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
    AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies.
    Brady M; Tolley E
    BJOG; 2014 Oct; 121 Suppl 5():70-8. PubMed ID: 25335843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health.
    Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J
    Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
    Krovi SA; Johnson LM; Luecke E; Achilles SL; van der Straten A
    Adv Drug Deliv Rev; 2021 Sep; 176():113849. PubMed ID: 34186143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approach.
    Young Holt B; Romano J; Manning J; Hemmerling A; Shields W; Vyda L; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():3-8. PubMed ID: 25335832
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: strategic insights from key stakeholders†.
    Hemmerling A; Christopher E; Young Holt B
    Biol Reprod; 2020 Aug; 103(2):289-298. PubMed ID: 32639007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive choice and acceptability: the future for STI risk in Kelantan, Malaysia.
    Shiely F; Saifuddin MS
    Int J STD AIDS; 2014 Mar; 25(3):219-27. PubMed ID: 23970646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipurpose prevention technologies: products in development.
    Friend DR; Clark JT; Kiser PF; Clark MR
    Antiviral Res; 2013 Dec; 100 Suppl():S39-47. PubMed ID: 24188708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.